Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 212 | 65 | 2 |
| Full Text Views | 9 | 3 | 0 |
| PDF Downloads | 14 | 4 | 0 |
Plasmodium Falciparum: Inhibition of in Vitro Growth by Desferrioxamine
Carmen Raventos-Suarez
Carmen Raventos-Suarez
Division of Experimental Hematology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461
Search for other papers by Carmen Raventos-Suarez in
Current site
Google Scholar
PubMed
Search for other papers by Carmen Raventos-Suarez in
Current site
Google Scholar
PubMed
Simeon Pollack
Simeon Pollack
Division of Experimental Hematology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461
Search for other papers by Simeon Pollack in
Current site
Google Scholar
PubMed
Search for other papers by Simeon Pollack in
Current site
Google Scholar
PubMed
Ronald L. Nagel
Ronald L. Nagel
Division of Experimental Hematology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461
Search for other papers by Ronald L. Nagel in
Current site
Google Scholar
PubMed
Search for other papers by Ronald L. Nagel in
Current site
Google Scholar
PubMed
Infectious agents must acquire iron from their host to survive, and iron deficiency has been reported to protect against malaria in humans. We have tested the the susceptibility of Plasmodium falciparum to iron deprivation by studying the effect of desferrioxamine (DF), a specific iron chelating agent, on parasite growth in an in vitro culture system. We have found that DF inhibits the growth of P. falciparum at concentrations readily achievable in vivo, by a mechanism that may involve interference with the completion of schizogony.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 212 | 65 | 2 |
| Full Text Views | 9 | 3 | 0 |
| PDF Downloads | 14 | 4 | 0 |